Pretransplant and posttransplant monitoring of anti-HLA class I IgG1 antibodies by ELISA identifies patients at high risk of graft loss

Transplant Proc. 1997 Feb-Mar;29(1-2):1433-4. doi: 10.1016/s0041-1345(96)00541-6.

Authors

F Monteiro¹, C Mineiro, H Rodrigues, F J de Paula, J Kalil

Affiliation

¹ Laboratory of Transplantation Immunology, School of Medicine, University of São Paulo, Brazil.

PMID: 9123368
DOI: 10.1016/s0041-1345(96)00541-6

No abstract available

Publication types

Comparative Study

MeSH terms

Analysis of Variance
Cytotoxicity, Immunologic
Enzyme-Linked Immunosorbent Assay / methods
Follow-Up Studies
Graft Rejection / epidemiology
Graft Rejection / immunology
Graft Survival / immunology*
Histocompatibility Antigens Class I / immunology*
Immunoglobulin G / blood*
Isoantibodies / blood*
Kidney Transplantation / immunology*
Monitoring, Physiologic
Predictive Value of Tests
Retrospective Studies
Time Factors
Treatment Failure

Substances

Histocompatibility Antigens Class I
Immunoglobulin G
Isoantibodies